IP Library Granted Patent US 7,592,372
Granted Patent B2
US 7,592,372 · App. 10/477,758 · Granted Sep 22, 2009

Liquid drug preparations

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,592,372
App. No.
10/477,758
Granted
Sep 22, 2009
Kind
B2
Abstract

Liquid drug preparations characterized by containing fudostein and an acid together with a sweetener such as sugar alcohol, trehalose or a sweetener having a high degree of sweetness. These liquid drug preparations are fudostein-containing liquid drug preparations which are free from color change or sedimentation upon prolonged storage and can be easily taken.

Claims (9)

1. A liquid drug preparation comprising fudosteine and an acid and having a pH of 2.5 to 4.0, wherein the liquid drug preparation is formulated to be suitable for oral administration in a patient in need of fudosteine administration.

2. The liquid drug preparation according to claim 1 , further comprising sugar alcohol in an amount of less than 40% by mass, trehalose in an amount of less than 40% by mass, or a sweetener having a high degree of sweetness as a sweetener in an amount of 0.01 to 1.0% by mass.

3. The liquid drug preparation according to claim 2 , comprising the sugar alcohol which is D-sorbitol, D-mannitol, xylytol, or erythritol.

4. The liquid drug preparation according to claim 2 , comprising the sweetener having a high degree of sweetness which is stevia, aspartame, saccharin, or sodium saccharin.

5. The liquid drug preparation according to claim 1 , wherein the acid is selected from the group consisting of hydrochloric acid, phosphoric acid, sulfuric acid, malic acid, citric acid, tartaric acid, lactic acid, fumaric acid, and combinations thereof.

6. The liquid drug preparation according to claim 2 , wherein the acid is selected from the group consisting of hydrochloric acid, phosphoric acid, sulfuric acid, malic acid, citric acid, tartaric acid, lactic acid, fumaric acid, and combinations thereof.

7. The liquid drug preparation according to claim 3 , wherein the acid is selected from the group consisting of hydrochloric acid, phosphoric acid, sulfuric acid, malic acid, citric acid, tartaric acid, lactic acid, fumaric acid, and combinations thereof.

8. The liquid drug preparation according to claim 4 , wherein the acid is selected from the group consisting of hydrochloric acid, phosphoric acid, sulfuric acid, malic acid, citric acid, tartaric acid, lactic acid, fumaric acid, and combinations thereof.

9. A liquid drug preparation comprising fudosteine and an acid and having a ph of 3.0 to 4.0.

Assignments (4)
MERGER Recorded May 4, 2007
From: HISAMITSU MEDICAL CO., LTD.
To: HISAMITSU PHARMACEUTICAL CO., INC.
Reel/Frame 019246/0969 →
CHANGE OF NAME Recorded Jun 14, 2005
From: BIOMEDIX CO., LTD.
To: HISAMITSU MEDICAL CO., LTD.
Reel/Frame 016323/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2005
From: SSP CO., LTD.
To: BIOMEDIX CO., LTD.
Reel/Frame 016004/0422 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2004
From: OSUGI, TOMOHIKO; FUSHIMI, MASUNARI; MURATA, YUTAKA; KANEKO, TETSUO; IMAMORI, KATSUMI
To: SSP CO., LTD.
Reel/Frame 015270/0084 →